Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Editorial: Performance Modeling and Anti-doping.

Faiss R, Saugy M, Passfield L, Hopker J.

Front Physiol. 2019 Mar 1;10:169. doi: 10.3389/fphys.2019.00169. eCollection 2019. No abstract available.

2.

Standardization of reticulocyte counts in the athlete biological passport.

Naud JF, Giraud S, Robinson N, Desharnais P, Ericsson M, Saugy M, Kuuranne T, Ayotte C, Boghosian T, Aikin R, Sottas PE.

Int J Lab Hematol. 2019 Feb 19. doi: 10.1111/ijlh.12988. [Epub ahead of print]

PMID:
30779426
3.

Worldwide distribution of blood values in elite track and field athletes: Biomarkers of altered erythropoiesis.

Robinson N, Saugy J, Schütz F, Faiss R, Baume N, Giraud S, Saugy M.

Drug Test Anal. 2019 Apr;11(4):567-577. doi: 10.1002/dta.2526. Epub 2018 Nov 12.

PMID:
30345707
4.

[The necessary dialogue between medicine and anti-doping for the integrity of sport and the athlete].

Faiss R, Salamin O, Astolfi T, Saugy M.

Rev Med Suisse. 2018 Jul 11;14(613):1360-1363. French.

PMID:
29998639
5.

UHPLC-HRMS Analysis for Steroid Profiling in Serum (Steroidomics).

Ponzetto F, Boccard J, Nicoli R, Kuuranne T, Saugy M, Rudaz S.

Methods Mol Biol. 2018;1738:261-278. doi: 10.1007/978-1-4939-7643-0_18.

PMID:
29654596
6.

Loop-mediated isothermal amplification (LAMP) as an alternative to PCR: A rapid on-site detection of gene doping.

Salamin O, Kuuranne T, Saugy M, Leuenberger N.

Drug Test Anal. 2017 Nov;9(11-12):1731-1737. doi: 10.1002/dta.2324. Epub 2017 Nov 23.

PMID:
29045058
7.

Transcriptomic biomarkers of altered erythropoiesis to detect autologous blood transfusion.

Salamin O, Mignot J, Kuuranne T, Saugy M, Leuenberger N.

Drug Test Anal. 2018 Mar;10(3):604-608. doi: 10.1002/dta.2240. Epub 2017 Aug 9.

PMID:
28670860
8.

Integration of the Forensic Dimension into Anti-Doping Strategies.

Marclay F, Saugy M.

Med Sport Sci. 2017;62:129-138. doi: 10.1159/000460723. Epub 2017 Jun 1.

PMID:
28571028
9.

High-resolution mass spectrometry as an alternative detection method to tandem mass spectrometry for the analysis of endogenous steroids in serum.

Ponzetto F, Boccard J, Baume N, Kuuranne T, Rudaz S, Saugy M, Nicoli R.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 May 1;1052:34-42. doi: 10.1016/j.jchromb.2017.03.016. Epub 2017 Mar 18.

PMID:
28346887
10.

RNA stabilized blood tubes to measure haemoglobin concentration.

Leuenberger N, Schobinger C, Salamin O, Saugy M, Kuuranne T.

Drug Test Anal. 2017 Jun;9(6):942-943. doi: 10.1002/dta.2179. Epub 2017 Apr 17. No abstract available.

PMID:
28266798
11.

Erythropoietin as a performance-enhancing drug: Its mechanistic basis, detection, and potential adverse effects.

Salamin O, Kuuranne T, Saugy M, Leuenberger N.

Mol Cell Endocrinol. 2018 Mar 15;464:75-87. doi: 10.1016/j.mce.2017.01.033. Epub 2017 Jan 22. Review.

PMID:
28119134
12.

Hepcidin as a potential biomarker for blood doping.

Leuenberger N, Bulla E, Salamin O, Nicoli R, Robinson N, Baume N, Saugy M.

Drug Test Anal. 2017 Jul;9(7):1093-1097. doi: 10.1002/dta.2122. Epub 2016 Nov 18.

PMID:
27758046
13.

Risk of false positive results to SARM S-4 in case of therapeutic use of antineoplastic/antiandrogen drug containing flutamide: a case study.

Perrenoud L, Schweizer Grundisch C, Baume N, Saugy M, Nicoli R.

Drug Test Anal. 2016 Nov;8(11-12):1109-1113. doi: 10.1002/dta.2051. Epub 2016 Aug 23. No abstract available.

PMID:
27511110
14.

Impact of blood transfusion on gene expression in human reticulocytes.

Salamin O, Barras L, Robinson N, Baume N, Tissot JD, Pitsiladis Y, Saugy M, Leuenberger N.

Am J Hematol. 2016 Oct;91(10):E460-1. doi: 10.1002/ajh.24470. Epub 2016 Jul 20. No abstract available.

15.

Methods for Doping Detection.

Ponzetto F, Giraud S, Leuenberger N, Boccard J, Nicoli R, Baume N, Rudaz S, Saugy M.

Front Horm Res. 2016;47:153-67. doi: 10.1159/000445177. Epub 2016 Jun 27. Review.

PMID:
27348309
16.

Autologous Blood Transfusion in Sports: Emerging Biomarkers.

Salamin O, De Angelis S, Tissot JD, Saugy M, Leuenberger N.

Transfus Med Rev. 2016 Jul;30(3):109-15. doi: 10.1016/j.tmrv.2016.05.007. Epub 2016 May 21. Review.

PMID:
27260108
17.

Pre-analytical and analytical aspects of EDTA-plasma iron measurement.

Leuenberger N, Baume N, Robinson N, Saugy M.

Drug Test Anal. 2016 Oct;8(10):1077-1079. doi: 10.1002/dta.1934. Epub 2015 Dec 21.

PMID:
27187526
18.

Liquid chromatography and supercritical fluid chromatography as alternative techniques to gas chromatography for the rapid screening of anabolic agents in urine.

Desfontaine V, Nováková L, Ponzetto F, Nicoli R, Saugy M, Veuthey JL, Guillarme D.

J Chromatogr A. 2016 Jun 17;1451:145-155. doi: 10.1016/j.chroma.2016.05.004. Epub 2016 May 3.

PMID:
27185056
19.

Circulating microRNA-122 as Potential Biomarker for Detection of Testosterone Abuse.

Salamin O, Jaggi L, Baume N, Robinson N, Saugy M, Leuenberger N.

PLoS One. 2016 May 12;11(5):e0155248. doi: 10.1371/journal.pone.0155248. eCollection 2016.

20.

Fast and sensitive supercritical fluid chromatography - tandem mass spectrometry multi-class screening method for the determination of doping agents in urine.

Nováková L, Desfontaine V, Ponzetto F, Nicoli R, Saugy M, Veuthey JL, Guillarme D.

Anal Chim Acta. 2016 Apr 7;915:102-10. doi: 10.1016/j.aca.2016.02.010. Epub 2016 Feb 12.

PMID:
26995645
21.

Hepcidin as a new biomarker for detecting autologous blood transfusion.

Leuenberger N, Barras L, Nicoli R, Robinson N, Baume N, Lion N, Barelli S, Tissot JD, Saugy M.

Am J Hematol. 2016 May;91(5):467-72. doi: 10.1002/ajh.24313. Epub 2016 Apr 6.

22.

Longitudinal monitoring of endogenous steroids in human serum by UHPLC-MS/MS as a tool to detect testosterone abuse in sports.

Ponzetto F, Mehl F, Boccard J, Baume N, Rudaz S, Saugy M, Nicoli R.

Anal Bioanal Chem. 2016 Jan;408(3):705-19. doi: 10.1007/s00216-015-9185-1. Epub 2015 Dec 16.

PMID:
26677027
23.

Circulating microRNAs: The Future of Biomarkers in Anti-doping Field.

Leuenberger N, Saugy M.

Adv Exp Med Biol. 2015;888:401-8. doi: 10.1007/978-3-319-22671-2_20.

PMID:
26663194
24.

Urinary di-(2-ethylhexyl) phthalate metabolites for detecting transfusion of autologous blood stored in plasticizer-free bags.

Leuenberger N, Barras L, Nicoli R, Robinson N, Baume N, Lion N, Barelli S, Tissot JD, Saugy M.

Transfusion. 2016 Mar;56(3):571-8. doi: 10.1111/trf.13408. Epub 2015 Nov 18.

PMID:
26581034
25.

Analytical Strategies for Doping Control Purposes: Needs, Challenges, and Perspectives.

Nicoli R, Guillarme D, Leuenberger N, Baume N, Robinson N, Saugy M, Veuthey JL.

Anal Chem. 2016 Jan 5;88(1):508-23. doi: 10.1021/acs.analchem.5b03994. Epub 2015 Nov 24. Review. No abstract available.

PMID:
26566004
26.

Blood monitoring of perfluorocarbon compounds (F-tert-butylcyclohexane, perfluoromethyldecalin and perfluorodecalin) by headspace-gas chromatography-tandem mass spectrometry.

Giuliani N, Saugy M, Augsburger M, Varlet V.

Talanta. 2015 Nov 1;144:196-203. doi: 10.1016/j.talanta.2015.05.015. Epub 2015 May 29.

PMID:
26452810
27.

Evaluation of longitudinal steroid profiles from male football players in UEFA competitions between 2008 and 2013.

Baume N, Geyer H, Vouillamoz M, Grisdale R, Earl M, Aguilera R, Cowan DA, Ericsson M, Gmeiner G, Kwiatkowska D, Kioukia-Fougia N, Molina A, Ruivo J, Segura J, Van Eenoo P, Jan N, Robinson N, Saugy M.

Drug Test Anal. 2016 Jul;8(7):603-12. doi: 10.1002/dta.1851. Epub 2015 Sep 3.

PMID:
26338140
28.

Evaluation of steroidomics by liquid chromatography hyphenated to mass spectrometry as a powerful analytical strategy for measuring human steroid perturbations.

Jeanneret F, Tonoli D, Rossier MF, Saugy M, Boccard J, Rudaz S.

J Chromatogr A. 2016 Jan 22;1430:97-112. doi: 10.1016/j.chroma.2015.07.008. Epub 2015 Jul 7. Review.

PMID:
26195035
29.

Influence of transport and time on blood variables commonly measured for the athlete biological passport.

Robinson N, Giraud S, Schumacher YO, Saugy M.

Drug Test Anal. 2016 Feb;8(2):199-207. doi: 10.1002/dta.1804. Epub 2015 Apr 29.

PMID:
25924812
30.

Antidoping programme and biological monitoring before and during the 2014 FIFA World Cup Brazil.

Baume N, Jan N, Emery C, Mandanis B, Schweizer C, Giraud S, Leuenberger N, Marclay F, Nicoli R, Perrenoud L, Robinson N, Dvorak J, Saugy M.

Br J Sports Med. 2015 May;49(9):614-22. doi: 10.1136/bjsports-2015-094762.

31.

Degradation of methyltestosterone in urine samples.

Schweizer Grundisch C, Baume N, Saugy M.

Drug Test Anal. 2014 Nov-Dec;6(11-12):1170-3. doi: 10.1002/dta.1761. No abstract available.

PMID:
25516451
32.

Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. II: Analysis of biological samples.

Nováková L, Rentsch M, Grand-Guillaume Perrenoud A, Nicoli R, Saugy M, Veuthey JL, Guillarme D.

Anal Chim Acta. 2015 Jan 1;853:647-659. doi: 10.1016/j.aca.2014.10.007. Epub 2014 Oct 13.

PMID:
25467514
33.

Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. I: Investigation of mobile phase and MS conditions.

Nováková L, Grand-Guillaume Perrenoud A, Nicoli R, Saugy M, Veuthey JL, Guillarme D.

Anal Chim Acta. 2015 Jan 1;853:637-646. doi: 10.1016/j.aca.2014.10.004. Epub 2014 Oct 14.

PMID:
25467513
34.

Untargeted profiling of urinary steroid metabolites after testosterone ingestion: opening new perspectives for antidoping testing.

Boccard J, Badoud F, Jan N, Nicoli R, Schweizer C, Pralong F, Veuthey JL, Baume N, Rudaz S, Saugy M.

Bioanalysis. 2014;6(19):2523-36. doi: 10.4155/bio.14.200.

PMID:
25411696
35.

Serum androgen levels in elite female athletes.

Bermon S, Garnier PY, Hirschberg AL, Robinson N, Giraud S, Nicoli R, Baume N, Saugy M, Fénichel P, Bruce SJ, Henry H, Dollé G, Ritzen M.

J Clin Endocrinol Metab. 2014 Nov;99(11):4328-35. doi: 10.1210/jc.2014-1391. Epub 2014 Aug 19.

PMID:
25137421
36.

The uefa euro 2012 anti-doping programme - scientific review.

Earl M, Vouillamoz M, Kwiatkowska D, Turek-Lepa E, Pokrywka A, Saugy M, Baume N, Gmeiner G.

Biol Sport. 2014 Jun;31(2):85-93. doi: 10.5604/20831862.1096037. Epub 2014 Apr 5. Review.

37.

A fast automated screening method for the detection of blood transfusion in sports.

Leuenberger N, Ansermet C, Pottgiesser T, Baume N, Robinson N, Saugy M, Schumacher YO.

Drug Test Anal. 2014 Nov-Dec;6(11-12):1141-3. doi: 10.1002/dta.1676. Epub 2014 May 22.

PMID:
24853344
38.

The effect of a period of intense exercise on the marker approach to detect growth hormone doping in sports.

Voss SC, Robinson N, Alsayrafi M, Bourdon PC, Schumacher YO, Saugy M, Giraud S.

Drug Test Anal. 2014 Jun;6(6):582-6. doi: 10.1002/dta.1666. Epub 2014 May 14.

PMID:
24827554
39.

Confounding factors and genetic polymorphism in the evaluation of individual steroid profiling.

Kuuranne T, Saugy M, Baume N.

Br J Sports Med. 2014 May;48(10):848-55. doi: 10.1136/bjsports-2014-093510. Review.

40.

Challenges and threats to implementing the fight against doping in sport.

Dvorak J, Saugy M, Pitsiladis YP.

Br J Sports Med. 2014 May;48(10):807-9. doi: 10.1136/bjsports-2014-093589.

PMID:
24764551
41.

Time for change: a roadmap to guide the implementation of the World Anti-Doping Code 2015.

Dvorak J, Baume N, Botré F, Broséus J, Budgett R, Frey WO, Geyer H, Harcourt PR, Ho D, Howman D, Isola V, Lundby C, Marclay F, Peytavin A, Pipe A, Pitsiladis YP, Reichel C, Robinson N, Rodchenkov G, Saugy M, Sayegh S, Segura J, Thevis M, Vernec A, Viret M, Vouillamoz M, Zorzoli M.

Br J Sports Med. 2014 May;48(10):801-6. doi: 10.1136/bjsports-2014-093561. Epub 2014 Apr 24.

42.

Drawing the map to implement the 2015 World Anti-Doping Code.

Dvorak J, Budgett R, Saugy M, Vernec A.

Br J Sports Med. 2014 May;48(10):800. doi: 10.1136/bjsports-2014-093653. No abstract available.

PMID:
24764549
43.

Determination of ¹³C/¹² C ratios of endogenous urinary 5-amino-imidazole-4-carboxamide 1β-D-ribofuranoside (AICAR).

Piper T, Thomas A, Baume N, Sobolevsky T, Saugy M, Rodchenkov G, Schänzer W, Thevis M.

Rapid Commun Mass Spectrom. 2014 Jun 15;28(11):1194-202. doi: 10.1002/rcm.6891.

PMID:
24760559
44.

Monitoring of biological markers indicative of doping: the athlete biological passport.

Saugy M, Lundby C, Robinson N.

Br J Sports Med. 2014 May;48(10):827-32. doi: 10.1136/bjsports-2014-093512. Epub 2014 Mar 21. Review.

PMID:
24659506
45.

Circulating miRNAs: a new generation of anti-doping biomarkers.

Leuenberger N, Robinson N, Saugy M.

Anal Bioanal Chem. 2013 Dec;405(30):9617-23. Review.

PMID:
24077830
46.

[Sports and athletes deserve doping hunting].

Gremion G, Saugy M.

Rev Med Suisse. 2013 Jul 17;9(393):1414-7. French.

PMID:
23971326
47.

Circulating microRNAs as biomarkers for detection of autologous blood transfusion.

Leuenberger N, Schumacher YO, Pradervand S, Sander T, Saugy M, Pottgiesser T.

PLoS One. 2013 Jun 20;8(6):e66309. doi: 10.1371/journal.pone.0066309. Print 2013.

48.

Profiling of steroid metabolites after transdermal and oral administration of testosterone by ultra-high pressure liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.

Badoud F, Boccard J, Schweizer C, Pralong F, Saugy M, Baume N.

J Steroid Biochem Mol Biol. 2013 Nov;138:222-35. doi: 10.1016/j.jsbmb.2013.05.018. Epub 2013 Jun 21.

PMID:
23796409
49.

Perspectives for Forensic Intelligence in anti-doping: thinking outside of the box.

Marclay F, Mangin P, Margot P, Saugy M.

Forensic Sci Int. 2013 Jun 10;229(1-3):133-44. doi: 10.1016/j.forsciint.2013.04.009. Epub 2013 May 4.

PMID:
23683919
50.

To what extent does adding tobacco to cannabis expose young users to nicotine?

Bélanger RE, Marclay F, Berchtold A, Saugy M, Cornuz J, Suris JC.

Nicotine Tob Res. 2013 Nov;15(11):1832-8. doi: 10.1093/ntr/ntt063. Epub 2013 May 14.

PMID:
23674840

Supplemental Content

Support Center